First Korean Case of Pediatric Acute Megakaryoblastic Leukemia with CBFA2T3::GLIS2 Fusion
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Acute megakaryoblastic leukemia (AMKL) is a rare type of acute myeloid leukemia that evolved from primitive megakaryoblasts. We report a case of non-Down syndrome AMKL with CBFA2T3::GLIS2 fusion that has not been described before in Korea. A 20-month-old girl presented with a fever and was diagnosed with AMKL after a bone marrow study and flow cytometry analysis. An RNA fusion test observed a fusion transcript between exons 9 and 2 of the CBFA2T3 and GLIS2 genes, respectively. The patient achieved complete morphological remission after induction chemotherapy. However, her prognosis was poor as measurable residual disease remained, detected using reverse transcription PCR. RNA fusion analysis could be a helpful tool to identify clinically actionable genomic markers for patient risk stratification and measurable residual disease monitoring.
Abstract
Acute megakaryoblastic leukemia (AMKL) is a rare type of acute myeloid leukemia that evolved from primitive megakaryoblasts. We report a case of non-Down syndrome AMKL with CBFA2T3::GLIS2 fusion that has not been described before in Korea. A 20-month-old girl presented with a fever and was diagnosed with AMKL after a bone marrow study and flow cytometry analysis. An RNA fusion test observed a fusion transcript between exons 9 and 2 of the CBFA2T3 and GLIS2 genes, respectively. The patient achieved complete morphological remission after induction chemotherapy. However, her prognosis was poor as measurable residual disease remained, detected using reverse transcription PCR. RNA fusion analysis could be a helpful tool to identify clinically actionable genomic markers for patient risk stratification and measurable residual disease monitoring.
참고문헌 (12)
- Bennett JM, "Proposals for the classification of the acute leukaemias. French-American-British(FAB)co-operative group", Br J Haematol, 33, pp.451~458 (1976)
- Masetti R, "CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype", Blood, 121, pp.3469~3472 (2013)
- Masetti R, "CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity", Br J Haematol, 184, pp.337~347 (2019)
- Arber DA, "International consensus classification of myeloid neoplasms and acute leukemias : integrating morphologic, clinical, and genomic data", Blood, 140, pp.1200~1228 (2022)
- Khoury JD, "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours : Myeloid and Histiocytic", Dendritic Neoplasms, 2022, pp.36, 1703~1719
- Thiollier C, "Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models", J Exp Med, 209, pp.2017~2031 (2012)
- Gruber TA, "An Inv(16)(p13. 3q24. 3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia", Cancer Cell, 22, pp.683~697 (2012)
- de Rooij JD, "Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes", Nat Genet, 49, pp.451~456 (2017)
- Smith JL, "Comprehensive Transcriptome Profiling of cryptic CBFA2T3-GLIS2 fusion-positive AML defines novel therapeutic options : a COG and TARGET Pediatric AML study", Clin Cancer Res, 26, pp.726~737 (2020)
- Haas BJ, "Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods", Genome Biol, 20, pp.213~ (2019)
- 조현정, "t(1;22)(p13;q13) 핵형에 의해 진단된 급성 거핵아 구성 백혈병 1예", Annals of Laboratory Medicine, 23(6), pp.371~374 (2003), 대한진단검사의학회
- 서보영, "Constitutional Chromosomal Abnormality Identified in a Sibling Donor After Bone Marrow Stem Cell Transplantation in a Pediatric Patient with Acute Megakaryoblastic Leukemia", Annals of Laboratory Medicine, 35(1), pp.162~164 (2015), 대한진단검사의학회